While other listed hospital stocks are struggling on the bourses, Apollo Hospitals has been hitting 52-week highs in recent weeks. The company has been an outlier among peers on expectation of better utilisation and performance in the hospitals business and value unlocking through monetisation of its pharmacy business.
The latter business is India’s largest, with over 3,000 stores and a standout segment in recent years. It was a prolonged weak earnings phase emanating from an aggressive expansion plan that had been responsible for earlier underperformance.
With earnings recovery taking root from the second half of 2017-18, and improvement in each quarter since,

)